| Ellen Cookie Gilchrist, RN, BSN, CDOE | |
|
14 Arbutus Trl, Coventry, RI 02816-6465 | |
| (401) 826-4659 | |
| Not Available |
| Full Name | Ellen Cookie Gilchrist |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Diabetes Educator |
| Location | 14 Arbutus Trl, Coventry, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710154034 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WD0400X | Registered Nurse - Diabetes Educator | RN35079 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ellen Cookie Gilchrist, RN, BSN, CDOE 14 Arbutus Trl, Coventry, RI 02816-6465 Ph: (401) 826-4659 | Ellen Cookie Gilchrist, RN, BSN, CDOE 14 Arbutus Trl, Coventry, RI 02816-6465 Ph: (401) 826-4659 |
News Archive
By correlating images of cancerous liver tissue with gene expression patterns, a research team led by a radiologist at the University of California, San Diego (UCSD) School of Medicine has developed tools that may some day allow physicians to view a CT image of a cancer tumor and discern its genetic activity.
Combining positron emission tomography scanning with iodine-124 (124I)–girentuximab may offer an effective noninvasive method of diagnosing clear cell renal cell carcinoma in patients who present with a renal mass, US study results suggest.
Aileron Therapeutics and Roche announced today that they have entered into a collaboration to discover, develop and commercialise a new class of drugs called Stapled Peptide Therapeutics. As part of this agreement, Roche will work with Aileron to develop drug candidates against up to five undisclosed targets selected from Roche's key therapeutic areas, which include oncology, virology, inflammation, metabolism and CNS.
A protein crucial for the immune response appears to be a key player in the progression of a devastating form of childhood leukemia called T-cell acute lymphoblastic leukemia (T-ALL). Suppressing the activity of the protein kills the leukemic cells, the study shows, opening a potential avenue to new drugs that could prevent progression of the disease.
› Verified 6 days ago
Mrs. Suzanne M Williams, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 85 Sandy Bottom Rd, Coventry, RI 02816 Phone: 401-821-0600 | |
Ms. Sharon Rapoza, RN, BSN, IBCLC, RLC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 45 Taft St, Coventry, RI 02816 Phone: 401-338-2245 | |
Janice R Martin, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 85 Sandy Bottom Rd, Coventry, RI 02816 Phone: 401-821-0600 | |
Taylor Dellagrotta, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 52 Cobblestone Ter, Coventry, RI 02816 Phone: 401-222-0944 | |
Emma P Vezikov, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 40 Ginger Trl, Coventry, RI 02816 Phone: 401-865-0003 | |
Samantha Falkowski, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 4 Notre Dame St, Coventry, RI 02816 Phone: 401-487-1646 | |
Mary-elizabeth Lavoie, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 87 Rawlinson Dr, Coventry, RI 02816 Phone: 401-623-1725 |